B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia and lymphoma.

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia and lymphoma. Stock Photo
Preview

Image details

Contributor:

molekuul.be / Alamy Stock Photo

Image ID:

J5K8AC

File size:

48 MB (1 MB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

4096 x 4096 px | 34.7 x 34.7 cm | 13.7 x 13.7 inches | 300dpi

Date taken:

10 May 2017

More information:

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Atoms shown as color-coded spheres. Per chain coloring.